Cibc World Market Inc. Teva Pharmaceutical Industries LTD Transaction History

Cibc World Market Inc.

  • $48 Billion
  • Q3 2024

A detailed history of Cibc World Market Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cibc World Market Inc. holds 129,796 shares of TEVA stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
129,796
Previous 131,988 1.66%
Holding current value
$2.96 Million
Previous $2.15 Million 9.04%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$15.81 - $18.96 $34,655 - $41,560
-2,192 Reduced 1.66%
129,796 $2.34 Million
Q2 2024

Aug 07, 2024
SELL
$12.78 - $17.4 $81,919 - $111,533
-6,410 Reduced 4.63%
131,988 $2.15 Million
Q1 2024

May 13, 2024
BUY
$10.67 - $14.43 $769,050 - $1.04 Million
72,076 Added 108.68%
138,398 $1.95 Million
Q4 2023

Feb 13, 2024
SELL
$8.12 - $10.63 $201,010 - $263,145
-24,755 Reduced 27.18%
66,322 $692,000
Q3 2023

Nov 13, 2023
BUY
$7.48 - $10.7 $21,692 - $31,029
2,900 Added 3.29%
91,077 $929,000
Q2 2023

Aug 11, 2023
BUY
$7.2 - $9.47 $5,760 - $7,576
800 Added 0.92%
88,177 $664,000
Q1 2023

May 12, 2023
SELL
$8.36 - $11.37 $24,244 - $32,973
-2,900 Reduced 3.21%
87,377 $773,000
Q4 2022

Feb 13, 2023
SELL
$7.95 - $9.48 $32,483 - $38,735
-4,086 Reduced 4.33%
90,277 $823,000
Q3 2022

Nov 10, 2022
BUY
$6.86 - $11.95 $103,414 - $180,146
15,075 Added 19.01%
94,363 $762,000
Q2 2022

Aug 10, 2022
SELL
$7.38 - $10.4 $6,605 - $9,308
-895 Reduced 1.12%
79,288 $596,000
Q1 2022

May 12, 2022
SELL
$7.33 - $9.39 $1,788 - $2,291
-244 Reduced 0.3%
80,183 $753,000
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $5,451 - $7,031
-690 Reduced 0.85%
80,427 $644,000
Q3 2021

Nov 12, 2021
BUY
$8.38 - $10.18 $28,659 - $34,815
3,420 Added 4.4%
81,117 $790,000
Q2 2021

Aug 12, 2021
BUY
$9.9 - $11.56 $7,920 - $9,248
800 Added 1.04%
77,697 $769,000
Q1 2021

May 11, 2021
SELL
$10.34 - $12.81 $78,584 - $97,356
-7,600 Reduced 8.99%
76,897 $887,000
Q4 2020

Feb 08, 2021
SELL
$8.61 - $11.04 $160,146 - $205,343
-18,600 Reduced 18.04%
84,497 $815,000
Q3 2020

Nov 12, 2020
SELL
$8.57 - $12.69 $487,684 - $722,137
-56,906 Reduced 35.57%
103,097 $929,000
Q2 2020

Aug 13, 2020
BUY
$8.12 - $13.12 $53,949 - $87,169
6,644 Added 4.33%
160,003 $1.97 Million
Q1 2020

May 15, 2020
SELL
$6.69 - $13.45 $78,172 - $157,163
-11,685 Reduced 7.08%
153,359 $1.38 Million
Q4 2019

Feb 13, 2020
SELL
$6.53 - $10.72 $508,047 - $834,037
-77,802 Reduced 32.04%
165,044 $1.62 Million
Q3 2019

Nov 13, 2019
SELL
$6.16 - $9.6 $31,040 - $48,374
-5,039 Reduced 2.03%
242,846 $1.67 Million
Q2 2019

Aug 08, 2019
SELL
$8.12 - $15.72 $1.1 Million - $2.14 Million
-136,044 Reduced 35.43%
247,885 $2.29 Million
Q1 2019

May 09, 2019
SELL
$15.58 - $20.01 $652,100 - $837,518
-41,855 Reduced 9.83%
383,929 $6.02 Million
Q4 2018

Feb 13, 2019
SELL
$14.59 - $23.84 $1.61 Million - $2.63 Million
-110,359 Reduced 20.58%
425,784 $6.57 Million
Q3 2018

Nov 09, 2018
BUY
$21.06 - $25.65 $987,440 - $1.2 Million
46,887 Added 9.58%
536,143 $11.5 Million
Q2 2018

Aug 08, 2018
BUY
$16.77 - $24.71 $1.56 Million - $2.3 Million
93,126 Added 23.51%
489,256 $11.9 Million
Q1 2018

May 18, 2018
BUY
$16.68 - $22.07 $4.28 Million - $5.67 Million
256,698 Added 184.1%
396,130 $6.77 Million
Q4 2017

Feb 01, 2018
SELL
$11.23 - $19.1 $366,221 - $622,870
-32,611 Reduced 18.96%
139,432 $2.64 Million
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $2.65 Million - $5.53 Million
172,043
172,043 $3.03 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email